FSLR enters September with the stock down 16% over the past month, shorts no longer in full retreat, and an October 27 earnings date now firmly in view — a setup where the tension between covering pressure and renewed caution is the story worth watching.
Ten days ago, the August 26 note described shorts covering at pace, with short interest having pulled back sharply to 9.1% of the free float. That covering impulse now looks like it has stalled. The stock has shed another 1.4% on the week and 1.6% on Friday alone, and with SI still meaningful at that level, the question is whether bears who covered are beginning to rebuild. The borrow market continues to offer no friction: availability remains well-supplied and cost to borrow is near-negligible, meaning there is nothing in the lending structure to prevent fresh short accumulation if sentiment sours further. Positioning looks more in flux than it did a fortnight ago.
Options traders are leaning defensive, and the posture has been consistent. The put/call ratio had already climbed toward 1.8 standard deviations above its 20-day average by late August. With the stock now another leg lower into September, that hedging demand is unlikely to have eased. A Q4 earnings date on October 27 gives the options market roughly seven weeks of event horizon — enough for protection-seeking to remain elevated without becoming extreme.
The Street's conviction on upside is notable, even if it hasn't translated into price action. The analyst recommendation differential ranks in the 98th percentile of the universe — meaning the gap between where analysts think FSLR trades and where they think it should trade is wider than almost any other name. The EPS surprise factor scores at the 75th percentile, reflecting a history of beating estimates. But the forward growth picture has weakened materially: forward EPS growth year-on-year has swung negative, and the 30-day and 90-day EPS momentum scores sit at just 11 and 31 respectively. The bull case rests on CdTe thin-film pricing strength and backlog execution. The bear case is that guidance has been cut and quality concerns persist. Valuation data from the ORTEX feed is stale (248 days old) and should not be relied upon for multiples analysis this week.
The most interesting institutional footnote is Capital Research and Management, which added 3.7 million shares as of the last reported period — a move that dwarfs every other holder's change and makes them the fifth-largest institutional name on the register. BlackRock and State Street also added modestly, while Vanguard Portfolio trimmed slightly. The ownership base is broadly supportive, but the Capital Research build stands out as a conviction signal worth tracking against the stock's continued weakness.
The last earnings print, on July 30, produced a 5.8% one-day gain and a 22.8% five-day rally — the strongest short-term reaction in the recent history. That result reset expectations higher. The October 27 print therefore arrives with the stock down 16% from where it was a month after that beat, making the question less about whether FSLR can beat and more about whether the market believes the forward guide has stabilised.
See the live data behind this article on ORTEX.
Open FSLR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
